SCPC Applauds President Trump’s Executive Order Calling on HHS and Congress to Improve the IRA, Rein In PBMs and Lower Drug Costs
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement applauding President Trump’s recent Executive Order aimed at improving the Inflation Reduction Act (IRA), lowering drug prices and addressing the harmful actions of PBMs.
“For far too long, pharmacy benefit managers (PBMs) have taken advantage of the lack of transparency in our healthcare system, establishing monopolistic control over the delivery of pharmacy services and significantly increasing what Americans pay for prescription medications. Anticompetitive PBMs practices have created a healthcare crisis, threatening the survival of pharmacies, including those that provide essential services to millions of patients in long-term care.”
“We commend President Trump’s efforts to address harmful PBM behavior by restoring competition, ensuring fair contracting and promoting transparency in our healthcare system. We encourage leaders in Congress—especially those who have already been championing PBM reform—to heed the President’s call for action and deliver meaningful reform that protects LTC pharmacies and the millions of seniors they serve.”
“LTC pharmacies are uniquely impacted by both aggressive PBM actions and recent Medicare Part D drug pricing policy changes included in the Inflation Reduction Act (IRA) that threaten the viability of many essential pharmacies across the country. The current Medicare pharmacy payment model is broken and forces LTC pharmacies to dispense medicines at a loss while PBMs and Part D plans reap massive profits. This problem will only worsen when new Medicare negotiated drug prices take effect in January 2026.”
“While there are many details for Congress to consider, Members must quickly follow through on President Trump’s Executive Order to protect seniors’ access to medicines and essential pharmacy services. We look forward to working with the White House, HHS and Congressional leaders to establish meaningful policy solutions that ensure the continued delivery of quality long-term care, support continued pharmaceutical innovation and protect the needs of America’s most vulnerable patients.”
Statement should be attributed to Alan Rosenbloom, President and CEO of SCPC.
###
Recent Posts
-
Senior Care Pharmacy Coalition Releases Statement in Support of the PBM Price Transparency and Accountability Act
SCPC commends Senators Mike Crapo (R-ID) and Ron Wyden (D-OR) for championing federal PBM reform through bipartisan legislation that targets the predatory practices of pharmacy benefit managers. These abuses continue to harm patients across the nation, particularly America’s seniors and the LTC pharmacies dedicated to serving them.
-
Op-ed: Trump Administration must act to preserve senior care
During my years representing the rural communities of southcentral
Pennsylvania, I learned that when a system works smoothly and
efficiently, people take it for granted. -
Medicare Part D 2027 MFP Drugs Underscores the Urgent Need for Congress to Pass H.R. 5031 / S. 3159
The Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, released the following statement regarding the pricing announcement of 2027 MFP drugs under the Medicare Part D drug price negotiation program. “The Centers for Medicaid and Medicare Services’ (CMS) announcement of the negotiated prices for the 2027 Medicare […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.